ERAS
Erasca Inc.
$17.36
+$0.42(+2.48%)
50
Overall
60
Value
63
Tech
28
Quality
Market Cap
$5.30B
Volume
3.35M
52W Range
$1.01 - $18.18
Target Price
$17.70
Latest News for ERAS
Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007
TipRanks Clinical-Trials-Auto-Generated Newsdesk•15 days ago•Mar 25, 2026
Erasca, Inc. ($ERAS) announced an update on their ongoing clinical study. The HERKULES-3 trial, officially titled “A Phase 1b/2 Study of Agents Tar......
Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007
TipRanks Clinical-Trials-Auto-Generated Newsdesk•15 days ago•Mar 25, 2026
Erasca, Inc. ($ERAS) announced an update on their ongoing clinical study. The HERKULES-3 trial, officially titled “A Phase 1b/2 Study of Agents Tar......
Analysts Are Bullish on Top Healthcare Stocks: Savara (SVRA), Erasca (ERAS)
Catie Powers•25 days ago•Mar 16, 2026
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Savara (SVRA – Research Report), Erasca (ERAS – Rese......
Mizuho Securities Remains a Buy on Erasca (ERAS)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago•Mar 15, 2026
Mizuho Securities analyst Joseph Catanzaro maintained a Buy rating on Erasca on March 13 and set a price target of $19.00. The company’s shares clo......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ERAS | $17.36 | +2.5% | 3.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |